266 related articles for article (PubMed ID: 24112947)
21. Impact of family involvement on social cognition training in clinically stable outpatients with schizophrenia -- a randomized pilot study.
Tas C; Danaci AE; Cubukcuoglu Z; Brüne M
Psychiatry Res; 2012 Jan; 195(1-2):32-8. PubMed ID: 21831453
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of remission and recovery in schizophrenia in the Czech Republic.
Prikryl R; Kholova M; Kucerova HP; Ceskova E
Compr Psychiatry; 2013 Oct; 54(7):1111-6. PubMed ID: 23810077
[TBL] [Abstract][Full Text] [Related]
23. Lower subjective quality of life and the development of social anxiety symptoms after the discharge of elderly patients with remitted schizophrenia: a 5-year longitudinal study.
Kumazaki H; Kobayashi H; Niimura H; Kobayashi Y; Ito S; Nemoto T; Sakuma K; Kashima H; Mizuno M
Compr Psychiatry; 2012 Oct; 53(7):946-51. PubMed ID: 22554765
[TBL] [Abstract][Full Text] [Related]
24. Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia.
Marder SR; Wirshing WC; Mintz J; McKenzie J; Johnston K; Eckman TA; Lebell M; Zimmerman K; Liberman RP
Am J Psychiatry; 1996 Dec; 153(12):1585-92. PubMed ID: 8942455
[TBL] [Abstract][Full Text] [Related]
25. Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community.
Bernardo M; Cañas F; Herrera B; García Dorado M
Rev Psiquiatr Salud Ment; 2017; 10(3):149-159. PubMed ID: 27291833
[TBL] [Abstract][Full Text] [Related]
26. Generalization of cognitive training in an Australian sample of schizophrenia patients.
Sharip S; Michie P; Schall U; Drysdale K; Case V; Sankaranarayanan A; Sidi H; Das S
Compr Psychiatry; 2013 Oct; 54(7):865-72. PubMed ID: 23602388
[TBL] [Abstract][Full Text] [Related]
27. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
[TBL] [Abstract][Full Text] [Related]
28. Patient-based and clinician-based support for the remission criteria in schizophrenia.
Docherty JP; Bossie CA; Lachaux B; Bouhours P; Zhu Y; Lasser R; Gharabawi GM
Int Clin Psychopharmacol; 2007 Jan; 22(1):51-5. PubMed ID: 17159460
[TBL] [Abstract][Full Text] [Related]
29. Metacognitive and social cognition training (MSCT) in schizophrenia: a preliminary efficacy study.
Rocha NB; Queirós C
Schizophr Res; 2013 Oct; 150(1):64-8. PubMed ID: 23962827
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
31. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
[TBL] [Abstract][Full Text] [Related]
32. Social skills training for schizophrenic individuals at risk for relapse.
Liberman RP; Mueser KT; Wallace CJ
Am J Psychiatry; 1986 Apr; 143(4):523-6. PubMed ID: 2869704
[TBL] [Abstract][Full Text] [Related]
33. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
[TBL] [Abstract][Full Text] [Related]
34. Adjunctive psychosocial therapies for the treatment of schizophrenia.
Patterson TL; Leeuwenkamp OR
Schizophr Res; 2008 Mar; 100(1-3):108-19. PubMed ID: 18226500
[TBL] [Abstract][Full Text] [Related]
35. [Social functioning and quality of life in schizophrenia patients --relationship with symptomatic remission and duration of illness].
Górna K; Jaracz K; Jaracz J; Kiejda J; Grabowska-Fudala B; Rybakowski J
Psychiatr Pol; 2014; 48(2):277-88. PubMed ID: 25016765
[TBL] [Abstract][Full Text] [Related]
36. Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remission.
Bobes J; Ciudad A; Alvarez E; San L; Polavieja P; Gilaberte I
Schizophr Res; 2009 Nov; 115(1):58-66. PubMed ID: 19729283
[TBL] [Abstract][Full Text] [Related]
37. Effects of social skills training and social milieu treatment on symptoms of schizophrenia.
Dobson DJ; McDougall G; Busheikin J; Aldous J
Psychiatr Serv; 1995 Apr; 46(4):376-80. PubMed ID: 7788460
[TBL] [Abstract][Full Text] [Related]
38. Neuropsychological predictors of functional outcome in Cognitive Behavioral Social Skills Training for older people with schizophrenia.
Granholm E; McQuaid JR; Link PC; Fish S; Patterson T; Jeste DV
Schizophr Res; 2008 Mar; 100(1-3):133-43. PubMed ID: 18222648
[TBL] [Abstract][Full Text] [Related]
39. Cognitive adaptation training combined with assertive community treatment: a randomised longitudinal trial.
Hansen JP; Østergaard B; Nordentoft M; Hounsgaard L
Schizophr Res; 2012 Mar; 135(1-3):105-11. PubMed ID: 22264599
[TBL] [Abstract][Full Text] [Related]
40. Remission and recovery during the first outpatient year of the early course of schizophrenia.
Ventura J; Subotnik KL; Guzik LH; Hellemann GS; Gitlin MJ; Wood RC; Nuechterlein KH
Schizophr Res; 2011 Oct; 132(1):18-23. PubMed ID: 21764563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
